Evidence mapPaperPMID 41978140Full record

ArticleNutrients2026

Post-Chemotherapy Changes and Agreement of CT-Derived Body Composition at L3 and T12 in Older Patients with Metastatic Colorectal Cancer: Associations with Nutritional Indices and Outcomes.

Anıl Yıldız, Melin Aydan Ahmed, Nihan Nizam Eren, Abdulmunir Azizy, Selay Artan, Simay Çokgezer, Bedirhan Ulufer, Ozan Deniz Aygörmez, Gündüz Karaoğlan, Şirin Zelal Şahin Tırnova and 7 more

Abstract read
In one paragraph

Article in Nutrients, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Anıl YıldızDepartment of Medical Oncology, Başaksehir Çam ve Sakura City Hospital, 34480 İstanbul, Türkiye.ORCID 0000-0002-6402-4445
Melin Aydan AhmedDepartment of Medical Oncology, Istanbul University Oncology Institute, 34093 İstanbul, Türkiye.ORCID 0000-0001-6271-9545
Nihan Nizam ErenDepartment of Medical Oncology, Bağcılar Research and Education Hospital, 34212 İstanbul, Türkiye.
Abdulmunir AzizyDepartment of Medical Oncology, Istanbul University Oncology Institute, 34093 İstanbul, Türkiye.ORCID 0000-0002-5068-6472
Selay ArtanDepartment of Medical Oncology, Istanbul University Oncology Institute, 34093 İstanbul, Türkiye.
Simay ÇokgezerDepartment of Medical Oncology, Istanbul University Oncology Institute, 34093 İstanbul, Türkiye.ORCID 0000-0002-5867-8776
Bedirhan UluferDepartment of Medical Oncology, Istanbul University Oncology Institute, 34093 İstanbul, Türkiye.
Ozan Deniz AygörmezDepartment of Medical Oncology, Istanbul University Oncology Institute, 34093 İstanbul, Türkiye.ORCID 0009-0001-8402-8945
Gündüz KaraoğlanDepartment of Medical Oncology, Başaksehir Çam ve Sakura City Hospital, 34480 İstanbul, Türkiye.
Şirin Zelal Şahin TırnovaDepartment of Internal Medicine, Division of Geriatrics, Istanbul Medical Faculty, Istanbul University, 34320 İstanbul, Türkiye.
Gulistan BahatDepartment of Internal Medicine, Division of Geriatrics, Istanbul Medical Faculty, Istanbul University, 34320 İstanbul, Türkiye.
Mustafa DurmazDepartment of Radiology, Istanbul University Oncology Institute, 34093 İstanbul, Türkiye.ORCID 0009-0000-4848-5201
İnci Kızıldağ YırgınDepartment of Radiology, Istanbul University Oncology Institute, 34093 İstanbul, Türkiye.
Senem KarabulutDepartment of Medical Oncology, Istanbul University Oncology Institute, 34093 İstanbul, Türkiye.
Burak SakarDepartment of Medical Oncology, Istanbul University Oncology Institute, 34093 İstanbul, Türkiye.
Mehmet Akif KaranDepartment of Internal Medicine, Division of Geriatrics, Istanbul Medical Faculty, Istanbul University, 34320 İstanbul, Türkiye.ORCID 0000-0002-9080-404X
Didem TaştekinDepartment of Medical Oncology, Istanbul University Oncology Institute, 34093 İstanbul, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAge- and cancer-related sarcopenia and malnutrition are common in older patients with colorectal cancer (CRC) and may negatively influence treatment tolerance and prognosis. However, the comparative prognostic value of post-chemotherapy changes in CT-based body composition parameters at the third lumbar vertebra (L3) and the twelfth thoracic vertebra (T12) levels, and their associations with nutritional indices, remain unclear. This study aimed to examine and compare the prognostic relevance of post-chemotherapy body composition changes at L3 and T12 and to assess their relationship with nutritional indices in older patients with metastatic CRC (mCRC).

methodsThis retrospective study included 87 older patients with mCRC. Baseline and ~3-month follow-up CT scans were analyzed at L3 and T12 using 3D Slicer to quantify skeletal muscle index (SMI), subcutaneous adipose tissue index (SATI), visceral adipose tissue index (VATI), visceral-to-subcutaneous fat ratio (VSR), and intramuscular adipose tissue index (IMATI). Changes (Δ) in CT-derived body composition after chemotherapy were calculated as percentage change using ((follow-up - baseline)/baseline) × 100. Prognostic Nutritional Index (PNI) and Geriatric Nutritional Index (GNRI), which are established nutritional assessment tools, were calculated from baseline laboratory/anthropometric data. Agreement between T12 and L3 was assessed, and associations with grade ≥ 3 toxicity, progression-free survival (PFS), and overall survival (OS) were evaluated using multivariable models and ROC analyses.

resultsMean age was 69.0 ± 4.5 years (59 male/28 female), and 26.4% developed grade ≥ 3 adverse events. Over 3 months, mean SMI declined significantly at both L3 (46.7 ± 8.8 → 42.8 ± 9.8 cm

conclusionsIn older patients with mCRC, early post-chemotherapy skeletal muscle loss-particularly at the L3 level-showed the strongest prognostic association with severe toxicity and mortality. GNRI provided complementary prognostic information as a marker of baseline immunonutritional reserve. Although T12-derived measurements were correlated with L3-derived values, systematic bias suggests that they should not be interpreted interchangeably for longitudinal risk stratification.

Indexed as

Body CompositionColorectal NeoplasmsNutritional StatusNutrition AssessmentTomography, X-Ray ComputedAgedAged, 80 and overFemaleHumansLumbar VertebraeMaleMalnutritionMuscle, SkeletalNeoplasm MetastasisPrognosisRetrospective Studieschemotherapy toxicityintramuscular adipose tissuemetastatic colorectal cancernutritional indexsarcopeniaskeletal muscle indexsurvival

Identifiers

PMID41978140
PMCPMC13074540

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.